In-Person Only
End users who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
Invited Audience
Tissue Engineering
Cell and Gene Manufacturing
Gene Therapy | Cell Therapy
Biomedical Engineering
Cell Line Development
Bioprocess Development
Quality Over Quantity
Technical Operations and Manufacturing
Investigational Material Supply Chain
Product Research and Development
Blockchain
Cohesive Networking
Regulatory Affairs
Regenerative Medicine
Cell Engineering
Immune Deficiencies
Stem Cell Manufacturing
​Novel Vector Systems
Speakers 30%
End Users 60%
Buying power 90%
Vendors 10%
Industrialisation & Commercialisation For Cell & Gene Therapy, Manufacturing & Supply
"The Global Cell and Gene Therapy Market is estimated to be up to $67 Billion by 2030."
The 6th Annual Cell and Gene Therapy Innovation Summit is an exclusive in-person-only gathering for up to 200 decision-makers, intellectual vanguards and captains of industry.
With more regenerative medicine products approaching clinical testing and commercialisation, seize this opportunity to hear detailed insights and industry best practices from renowned presenters.
#CGTI 2023 programme will highlight the manufacturing challenges facing Cell & Gene Therapy, bringing clear insights and industry best practices from industry leaders.
Achieve a deeper understanding of the many manufacturing and industrialisation burdens unique to carrying durable and curative therapies to needy patients.
The 6th Annual Cell And Gene Innovation Summit
15th - 16th February 2023 - Hotel Palace Berlin 5*
08:45 am
The Agenda
